| CCDTX | RFDTX | CCDTX / RFDTX | |
| Total Expense Ratio | 1.38 | 0.31 | 445% |
| Annual Report Gross Expense Ratio | 1.38 | 0.31 | 445% |
| Fund Existence | 12 years | 17 years | - |
| Gain YTD | 4.519 | 5.012 | 90% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 250 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 31.4B | 31.4B | 100% |
| Annual Yield % from dividends | 1.40 | 2.39 | 59% |
| Returns for 1 year | 7.00 | 8.25 | 85% |
| Returns for 3 years | 20.06 | 21.60 | 93% |
| Returns for 5 years | 9.61 | 15.38 | 62% |
| Returns for 10 years | 48.79 | 59.80 | 82% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ASHS | 46.72 | 0.93 | +2.03% |
| Xtrackers Harvest CSI 500 CHN A SmCp ETF | |||
| QVMT | 68.59 | 0.61 | +0.90% |
| Invesco S&P S&P 500 Concentrated QVM ETF | |||
| PBE | 84.64 | 0.20 | +0.24% |
| Invesco Biotechnology & Genome ETF | |||
| SEIV | 47.77 | 0.07 | +0.15% |
| SEI QiM U.S. Lrg Cap Value Actv ETF | |||
| ETHU | 13.50 | -0.45 | -3.23% |
| 2x Ether ETF | |||